US Stock MarketDetailed Quotes

ALUR Allurion Technologies

Watchlist
  • 1.230
  • -0.160-11.51%
Close Jun 14 16:00 ET
  • 1.200
  • -0.030-2.44%
Post 18:41 ET
58.98MMarket Cap-712P/E (TTM)

About Allurion Technologies Company

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.

Company Profile

SymbolALUR
Company NameAllurion Technologies
Listing DateMar 29, 2021
Founded2023
CEOMr. Shantanu Gaur
MarketNYSE
Employees252
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11 Huron Drive
CityNatick
ProvinceMassachusetts
CountryUnited States of America
Zip Code01760
Phone1-508-647-4000

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Shantanu Gaur, M.D.
  • Chief Executive Officer and Director
  • --
  • Ram Chuttani
  • Chief Medical Officer
  • --
  • Christopher Geberth
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Krishna K. Gupta
  • Co-Chairman of the Board
  • --
  • Michael R. Davin
  • Director
  • --
  • Larson Douglas Hudson
  • Director
  • --
  • Dr. Omar Ishrak
  • Director
  • --
  • Nicholas S. Lewin
  • Director
  • --
  • Milena Alberti-Perez
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg